Saturday, August 26th
  • About Us
  • Copyright
  • Disclaimer
  • Privacy Policy
  • Terms&Conditions
  • Contact Us
    • Advertisement
  • Site Map
Biosimilar News
  • Twitter
  • RSS
  • News/Headlines
  • Events
    • Upcoming Events
    • Past Events
  • Guidelines
  • Policies
  • Research/Analysis
USEFUL TIP: In order not to miss any updates, follow us on Twitter or sign up for our Newsletter..

Follow Us

  • Subscribe by RSS Subscribe by RSS
  •  Contact us via E-Mail
  •  Follow us on Twitter
  •  Follow us on LinkedIn
 

Sign up for our newsletter

All-time Popular Posts

  • A biobetter trastuzumab is on the way A biobetter trastuzumab is on the way
  • EGA president calls on Member States to boost market access for biosimilars in the EU EGA president calls on Member States to boost market access for biosimilars in the EU
  • 3rd Forum on Biosimilars 3rd Forum on Biosimilars
  • Pfizer starts biosimilar rituximab Phase I/II trial Pfizer starts biosimilar rituximab Phase I/II trial
  • Indian Biosimilars Market Indian Biosimilars Market
  • World’s first biosimilar antibody* is approved in Korea World’s first biosimilar antibody* is approved in Korea
  • A biosimilar manufacturer: Celltrion A biosimilar manufacturer: Celltrion
  • 2 patents down, 1 to expire: Herceptin biosimilar coming to EU 2 patents down, 1 to expire: Herceptin biosimilar coming to EU

Archives

Twitter Updates

Post Tagged with: "FDA"

August 3, 2017 6:42 AM

Amgen and Allergan submit biosimilar Biologics License Application for ABP 980 to US FDA

August 1, 2017 8:26 AM

Celltrion and Teva announce U.S. FDA acceptance of BLA for proposed biosimilar to Herceptin (trastuzumab)

July 25, 2017 12:13 PM

Merck announces launch of Renflexis (Remicade biosimilar) in the United States

July 24, 2017 7:14 AM

Merck receives tentative approval for LUSDUNA Nexvue (insulin glargine injection) from FDA

July 16, 2017 2:59 PM

FDA Oncologic Drugs Advisory Committee unanimously recommends approval of Mylan and Biocon’s proposed biosimilar trastuzumab

© Copyright 2017 — Biosimilar News. All Rights Reserved Powered by Wordpress